Protein kinase C θ activation induces insulin-mediated constriction of muscle resistance arteries

Diabetes

Volumn 57, Issue 3, 2008, Pages 706-713

  Bakker, Wineke ^a   Sipkema, Pieter ^a   Stehouwer, Coen D A ^b   Serne, Erik H ^a   Smulders, Yvo M ^a   Van Hinsbergh, Victor W M ^a   Eringa, Etto C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PALMITIC ACID; PROTEIN KINASE B; PROTEIN KINASE C THETA; THREONINE; ENDOTHELIN 1; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 6; PRKCQ PROTEIN, MOUSE; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE INACTIVATION; GRACILIS MUSCLE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; MALE; MOUSE; MYOGRAPHY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; WESTERN BLOTTING; ANIMAL; ARTERY; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SKELETAL MUSCLE; VASCULARIZATION;

ANIMALS; ARTERIES; ENDOTHELIN-1; HUMANS; INSULIN; ISOENZYMES; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 6; MUSCLE, SKELETAL; NITRIC OXIDE; PALMITIC ACID; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; VASOCONSTRICTION;

EID: 40949129628     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0792     Document Type: Article

References (48)

1. Reaven GM: Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. Kahn BB, Flier JS: Obesity and insulin resistance. J Clin Invest 106:473- 481, 2000
3. Frohlich ED, Messerli FH, Reisin E, Dunn FG: The problem of obesity and hypertension. Hypertension 5:III71-III78, 1983
4. Clark MG, Wallis MG, Barrett EJ, Vincent MA, Richards SM, Clerk LH, Rattigan S: Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab 284:E241-E258, 2003
5. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605, 1999
6. Vincent MA, Clerk LH, Lindner JR, Klibanov AL, Clark MG, Rattigan S, Barrett EJ: Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes 53:1418-1423, 2004
7. Eringa EC, Stehouwer CDA, Merlijn T, Westerhof N, Sipkema P: Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Cardiovasc Res 56:464-471, 2002
8. Eringa EC, Stehouwer CDA, Nieuw Amerongen GP, Ouwehand L, Westerhof N, Sipkema P: Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium. Am J Physiol Heart Circ Physiol 287:H2043-H2048, 2004
9. Potenza MA, Marasciulo FL, Chieppa DM, Brigiani GS, Formoso G, Quon MJ, Montagnani M: Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol 289:H813-H822, 2005
10. Lteif A, Vaishnava P, Baron AD, Mather KJ: Endothelin limits insulin action in obese/insulin-resistant humans. Diabetes 56:728-734, 2007
11. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 104:447-457, 1999
12. Baier G, Telford D, Giampa L, Coggeshall KM, Baier-Bitterlich G, Isakov N, Altman A: Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem 268:4997-5004, 1993
13. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-l)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236, 2002
14. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI: Free fatty acid-induced insulin resistance is associated with activation of protein kinase C è and alterations in the insulin signaling cascade. Diabetes 48:1270-1274, 1999
15. Donnelly R, Reed MJ, Azhar S, Reaven GM: Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology 135:2369-2374, 1994
16. Jove M, Planavila A, Sanchez RM, Merlos M, Laguna JC, Vazquez-Carrera M: Palmitate induces tumor necrosis factor-{alpha} expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-{kappa}B activation. Endocrinology 147:552-561, 2006
17. Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, Ye J: Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol 18:2024-2034, 2004
18. Li Y, Soos TJ, Li X, Wu J, DeGennaro M, Sun X, Liftman DR, Birnbaum MJ, Polakiewicz RD: Protein kinase C {theta} inhibits insulin signaling by phosphorylating IRS1 at Ser1101. J Biol Chem 279:45304-45307, 2004
19. Bradley EA, Clark MG, Rattigan S: Acute effects of wortmannin on insulin's hemodynamic and metabolic actions in vivo. Am J Physiol Endocrinol Metab 292:E779-E787, 2007
20. Clerk LH, Rattigan S, Clark MG: Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 51:1138-1145, 2002
21. Kim JK, Fillmore JJ, Sunshine MJ, Albrecht B, Higashimori T, Kim DW, Liu ZX, Soos TJ, Cline GW, O'Brien WR, Liftman DR, Shulman GI: PKC-{theta} knockout mice are protected from fat-induced insulin resistance. J Clin Invest 114:823-827, 2004
22. Itani SI, Pories WJ, MacDonald KG, Dohm GL: Increased protein kinase C theta in skeletal muscle of diabetic patients. Metabolism 50:553-557, 2001
23. Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, Gandhi L, Amies J, Petrzilka D, Kupfer A, Schwartzberg PL, Littman DR: PKC-[thetas] is required for TCR-induced NF-[kappa]B activation in mature but not immature T lymphocytes. Nature 404:402-407, 2000
24. Kim F, Tysseling KA, Rice J, Pham M, Haji L, Gallis BM, Baas AS, Paramsothy P, Giachelli CM, Corson MA, Raines EW: Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKK{beta}. Arterioscler Thromb Vase Biol 25:989-994, 2005
25. Newton AC: Protein kinase C: structure, function, and regulation. J Biol Chem 270:28495-28498, 1995
26. Hool LC: Protein kinase C isozyme selective peptides: a current view of what they tell us about location and function of isozymes in the heart. Curr Pharm Des 11:549-559, 2005
27. House C, Kemp BE: Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 238:1726-1728, 1987
28. Eichholtz T, de Bont DB, de Widt J, Liskamp RM, Ploegh HL: A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J Biol Chem 268:1982-1986, 1993
29. Eringa EC, Stehouwer CDA, Walburg K, Clark AD, Nieuw Amerongen GP, Westerhof N, Sipkema P: Physiological concentrations of insulin induce endothelin-dependent vasoconstriction of skeletal muscle resistance arteries in the presence of tumor necrosis factor-{alpha} dependence on c-Jun N-terminal kinase. Arterioscler Thromb Vase Biol 26:274-280, 2006
30. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD: Free fatty acid elevation impairs msulin-mediated vasodilation and nitric oxide production. Diabetes 49:1231-1238, 2000
31. Staehr P, Hother-Nielsen O, Levin K, Hoist JJ, Beck-Nielsen H: Assessment of hepatic insulin action in obese type 2 diabetic patients. Diabetes 50:1363-1370, 2001
32. Liu Y, Graham C, Li A, Fisher RJ, Shaw S: Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-kappaB induction. Biochem J 361:255-265, 2002
33. Xu ZB, Chaudhary D, Olland S, Wolfrom S, CzerwinsM E, Malakian K, Lin L, Stahl ML, Joseph-McCarthy D, Benander C, Fltz L, Greco R, Somers WS, Mosyak L: Catalytic domain crystal structure of protein kinase C-{theta} (PKC{theta)). J Biol Chem 279:50401-50409, 2004
34. Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, Panza JA: Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 100:820-825, 1999
35. Jones RD, Pugh PJ, Hall J, Channer KS, Jones TH: Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse. Eur J Endocrinol 148:111-120, 2003
36. Okada Y, Yanagisawa T, Taira N: KCl-depolarization potentiates the Ca2 + sensitization by endothelin-1 in canine coronary artery. Jpn J Pharmacol 60:403-405, 1992
37. Quaschning T, Rebhan B, Wunderlich C, Wanner C, Richter CM, Pfab T, Bauer C, Kraemer-Guth A, Galle J, Yanagisawa M, Hocher B: Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loading. J Hypertens 23:979-985, 2005
38. Cardillo C, Kilcoyne CM, Cannon RO III, Panza JA: Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 35:1237-1241, 2000
39. Gudbjornsdottir S, Elam M, Sellgren J, Anderson EA: Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives. J Hypertens 14:91-97, 1996
40. Hempel A, Maasch C, Heintze U, Lindschau C, Dietz R, Luft FC, Haller H: High glucose concentrations increase endothelial cell permeability via activation of protein kinase C{alpha}. Circ Res 81:363-371, 1997
41. Haller H, Ziegler W, Lindschau C, Luft FC: Endothelial cell tyrosine kinase receptor and G protein-coupled receptor activation involves distinct protein kinase C isoforms. Arterioscler Thromb Vasc Biol 16:678-686, 1996
42. Mattila P, Majuri ML, Tiisala S, Renkonen R: Expression of six protein kinase C isotypes in endothelial cells. Life Sci 55:1253-1260, 1994
43. Yang CM, Fen LW, Tsao HL, Chiu CT: Inhibition of 5-hydroxytryptamine- induced phosphoinositide hydrolysis and Ca2+ mobilization in canine cultured tracheal smooth muscle cells by phorbol ester. Br J Pharmacol 121:853-860, 1997
44. Wang YX, Ding YJ, Zhu YZ, Shi Y, Yao T, Zhu YC: Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction. Am J Physiol Heart Circ Physiol 292:H348- H359, 2007
45. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF: Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277:1531-1537, 2002
46. De Fea K, Roth RA: Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem 272:31400-31406, 1997
47. Mount PF, Kemp BE, Power DA: Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42:271-279, 2007
48. Serra C, Federici M, Buongiorno A, Senni MI, Morelli S, Segratella E, Pascuccio M, Tiveron C, Mattei E, Tatangelo L, Lauro R, Molinaro M, Giaccari A, Bouche M: Transgenic mice with dominant negative PKC-theta in skeletal muscle: a new model of insulin resistance and obesity. J Cell Physiol 196:89-97, 2003